Gillespie GY - Search Results

1

Human cytomegalovirus infection and expression in human malignant glioma.

Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. Cobbs CS, et al. Among authors: gillespie gy. Cancer Res. 2002 Jun 15;62(12):3347-50. Cancer Res. 2002. PMID: 12067971

2

Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.

Suswam E, Li Y, Zhang X, Gillespie GY, Li X, Shacka JJ, Lu L, Zheng L, King PH. Suswam E, et al. Among authors: gillespie gy. Cancer Res. 2008 Feb 1;68(3):674-82. doi: 10.1158/0008-5472.CAN-07-2751. Cancer Res. 2008. PMID: 18245466

3

The RNA-binding protein HuR promotes glioma growth and treatment resistance.

Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH, Wheeler C, Nabors LB. Filippova N, et al. Among authors: gillespie gy. Mol Cancer Res. 2011 May;9(5):648-59. doi: 10.1158/1541-7786.MCR-10-0325. Epub 2011 Apr 15. Mol Cancer Res. 2011. PMID: 21498545 Free PMC article.

4

HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.

Nabors LB, Gillespie GY, Harkins L, King PH. Nabors LB, et al. Among authors: gillespie gy. Cancer Res. 2001 Mar 1;61(5):2154-61. Cancer Res. 2001. PMID: 11280780

5

Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation.

Blanquicett C, Gillespie GY, Nabors LB, Miller CR, Bharara S, Buchsbaum DJ, Diasio RB, Johnson MR. Blanquicett C, et al. Among authors: gillespie gy. Mol Cancer Ther. 2002 Oct;1(12):1139-45. Mol Cancer Ther. 2002. PMID: 12481438

6

Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.

Stettner MR, Wang W, Nabors LB, Bharara S, Flynn DC, Grammer JR, Gillespie GY, Gladson CL. Stettner MR, et al. Among authors: gillespie gy. Cancer Res. 2005 Jul 1;65(13):5535-43. doi: 10.1158/0008-5472.CAN-04-3688. Cancer Res. 2005. PMID: 15994925

7

Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences.

Cobbs CS, Samanta M, Harkins LE, Gillespie GY, Merrick BA, MacMillan-Crow LA. Cobbs CS, et al. Among authors: gillespie gy. Arch Biochem Biophys. 2001 Oct 15;394(2):167-72. doi: 10.1006/abbi.2001.2540. Arch Biochem Biophys. 2001. PMID: 11594730

8

Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.

Hellums EK, Markert JM, Parker JN, He B, Perbal B, Roizman B, Whitley RJ, Langford CP, Bharara S, Gillespie GY. Hellums EK, et al. Among authors: gillespie gy. Neuro Oncol. 2005 Jul;7(3):213-24. doi: 10.1215/S1152851705000074. Neuro Oncol. 2005. PMID: 16053696 Free PMC article.

9

Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro.

Han X, Li R, Zhang W, Yang X, Wheeler CG, Friedman GK, Province P, Ding Q, You Z, Fathallah-Shaykh HM, Gillespie GY, Zhao X, King PH, Nabors LB. Han X, et al. Among authors: gillespie gy. J Neurooncol. 2014 May;118(1):61-72. doi: 10.1007/s11060-014-1419-0. Epub 2014 Mar 25. J Neurooncol. 2014. PMID: 24664369 Free PMC article.

10

Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.

Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY, Roizman B, Whitley RJ. Andreansky S, et al. Among authors: gillespie gy. Cancer Res. 1997 Apr 15;57(8):1502-9. Cancer Res. 1997. PMID: 9108452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters